TherapeuticsMD (TXMD) News Today $1.14 -0.04 (-3.39%) (As of 12/17/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period TherapeuticsMD (NASDAQ:TXMD) Now Covered by Analysts at StockNews.comDecember 16 at 2:48 AM | americanbankingnews.comTherapeuticsMD (NASDAQ:TXMD) Earns Hold Rating from Analysts at StockNews.comDecember 9, 2024 | americanbankingnews.comTherapeuticsMD Inc. stock underperforms Friday when compared to competitors despite daily gainsNovember 23, 2024 | marketwatch.comTherapeuticsMD Shifts Focus with Lower Q3 LossesNovember 15, 2024 | markets.businessinsider.comTherapeuticsMD Reports Reduced Losses Amid Strategic ShiftNovember 15, 2024 | markets.businessinsider.comTherapeuticsMD Announces Third Quarter 2024 Financial ResultsNovember 13, 2024 | finance.yahoo.comTherapeuticsMD Inc. stock remains steady Monday, underperforms marketNovember 12, 2024 | marketwatch.comTherapeuticsMD (NASDAQ:TXMD) Stock, Option ChainNovember 6, 2024 | benzinga.comTherapeuticsMD Inc. stock remains steady Wednesday, underperforms marketNovember 6, 2024 | marketwatch.comTherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors despite daily gainsOctober 22, 2024 | marketwatch.comTherapeuticsMD Inc. stock remains steady Thursday, underperforms marketOctober 17, 2024 | marketwatch.comTherapeuticsMD Inc. stock remains steady Friday, underperforms marketOctober 11, 2024 | marketwatch.comTherapeuticsMD Inc. stock remains steady Thursday, still outperforms marketOctober 11, 2024 | marketwatch.comTherapeuticsMD Inc. stock underperforms Monday when compared to competitors despite daily gainsSeptember 30, 2024 | marketwatch.comTherapeuticsMD Inc. stock rises Thursday, still underperforms marketSeptember 12, 2024 | marketwatch.comTherapeuticsMD Inc. stock underperforms Tuesday when compared to competitorsSeptember 3, 2024 | marketwatch.comTherapeuticsMD Inc. stock rises Friday, still underperforms marketAugust 24, 2024 | marketwatch.comTherapeuticsMD Inc. stock rises Tuesday, still underperforms marketAugust 13, 2024 | marketwatch.comTXMD Stock Earnings: TherapeuticsMD Reported Results for Q2 2024August 13, 2024 | investorplace.comTherapeuticsMD Announces Second Quarter 2024 Financial ResultsAugust 12, 2024 | finance.yahoo.comTXMD Stock Earnings: TherapeuticsMD Reported Results for Q4 2023June 28, 2024 | investorplace.comTherapeuticsMD, Inc. (TXMD) Stock Price, News, Quote & History - Yahoo FinanceMay 15, 2024 | finance.yahoo.comTXMD Stock Earnings: TherapeuticsMD Reported Results for Q1 2024May 10, 2024 | investorplace.comTherapeuticsMD Announces First Quarter 2024 Financial ResultsMay 10, 2024 | businesswire.comTherapeuticsMD Announces Full Year 2023 Financial ResultsMarch 29, 2024 | businesswire.com25 Countries With Highest Abortion RatesMarch 12, 2024 | msn.comTherapeuticsMD, Inc. (TXMD) stock historical prices & data – Yahoo FinanceMarch 10, 2024 | sg.finance.yahoo.comTherapeuticsMD Inc TXMDDecember 29, 2023 | morningstar.comDaily Markets: Today Brings Producer Prices, Retail Sales DataNovember 15, 2023 | nasdaq.comTherapeuticsMD to Consider Strategic AlternativesNovember 14, 2023 | marketwatch.comTherapeuticsMD exploring strategic alternatives for companyNovember 14, 2023 | msn.comTherapeuticsMD Announces Third Quarter 2023 Financial ResultsNovember 14, 2023 | finance.yahoo.comBoca Raton-based prescription service announces layoffs, says a third of workforce could be cutOctober 4, 2023 | bizjournals.comTherapeuticsMD Inc. stock falls Wednesday, underperforms marketSeptember 20, 2023 | marketwatch.comTherapeuticsMD Inc. stock outperforms market despite losses on the dayAugust 15, 2023 | marketwatch.comTherapeuticsMD Announces Second Quarter 2023 Financial ResultsAugust 14, 2023 | finance.yahoo.comMicron Biomedical Appoints Brian Bernick, MD as Chairman of Its Board of DirectorsAugust 9, 2023 | finance.yahoo.comTherapeuticsMD Inc. stock underperforms Wednesday when compared to competitorsJuly 5, 2023 | marketwatch.comTherapeuticsMD Rejected by FDA, Delay Could Be FatalJuly 4, 2023 | thestreet.comTherapeuticsMD: From Fallen And Forgotten To Cash CowMay 23, 2023 | seekingalpha.comTherapeuticsMD Announces First Quarter 2023 Financial ResultsMay 15, 2023 | finance.yahoo.comTherapeuticsMD Inc. stock falls Tuesday, underperforms marketMay 10, 2023 | marketwatch.comTherapeuticsMD Inc. stock rises Wednesday, still underperforms marketMay 10, 2023 | marketwatch.comTherapeuticsMD Inc. stock falls Monday, underperforms marketMay 3, 2023 | marketwatch.comTherapeuticsMD Inc. stock underperforms Friday when compared to competitorsApril 30, 2023 | marketwatch.comTherapeuticsMD Inc. stock outperforms market on strong trading dayApril 23, 2023 | marketwatch.comAll You Need to Know About TherapeuticsMD (TXMD) Rating Upgrade to BuyApril 14, 2023 | msn.comTherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model TransitionApril 7, 2023 | finance.yahoo.comTherapeuticsMD Inc. stock underperforms Monday when compared to competitorsMarch 13, 2023 | marketwatch.comTheraputicsMD sells products rights for $153 millionJanuary 5, 2023 | bizjournals.com Get TherapeuticsMD News Delivered to You Automatically Sign up to receive the latest news and ratings for TXMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Do this Before Elon’s Reveal on January 22nd (Ad)Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen. I urge you to watch this video now. TXMD Media Mentions By Week TXMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TXMD News Sentiment▼0.960.69▲Average Medical News Sentiment TXMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TXMD Articles This Week▼20▲TXMD Articles Average Week Get TherapeuticsMD News Delivered to You Automatically Sign up to receive the latest news and ratings for TXMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Immuneering News Shattuck Labs News IO Biotech News AlloVir News Iterum Therapeutics News Celularity News CASI Pharmaceuticals News vTv Therapeutics News Omega Therapeutics News Kezar Life Sciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TXMD) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TherapeuticsMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TherapeuticsMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TXMD Stock Alerts